Component
Viability of glioblastoma cells
Viability of glioblastoma cells. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
In glioblastoma cell lines mebendazole displayed cytotoxicity with half-maximal inhibitory concentrations ranging from 0.1 to 0.3 micromolar, disrupted microtubule formation in those cells with in vitro activity correlated with reduced tubulin polymerization, and significantly extended mean survival by up to 63% in syngeneic and xenograft orthotopic mouse glioma models; the programme began with the serendipitous observation that fenbendazole, used to treat pinworm infection, inhibited brain tumour engraftment.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/mebendazole-research/21764822.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "31b328d5c2340f7a4e9b6a3b3d46c68a8c0265c50d483375bc6dc15bb1696ad6", "start_char": 0, "end_char": 1210, "text_sha256": "31b328d5c2340f7a4e9b6a3b3d46c68a8c0265c50d483375bc6dc15bb1696ad6"}
- experimental_model
- Cell line cytotoxicity, tubulin polymerisation and syngeneic and xenograft orthotopic mouse glioma models
- exposure
- Mebendazole compared with fenbendazole, at doses documented as safe in humans
- limitations
- The observation that started the programme was serendipitous, from pinworm treatment of laboratory animals. Mouse models, and the survival gain is a mean rather than a cure.
- nutrient_topic
- Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms. · Mebendazole
- organism
- Human cells and mouse
- plain_language
- The worm drug killed brain tumour cells at low concentrations and let mice live substantially longer.
- primary_references
- [mbz-p21764822] Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme. (2011). https://pubmed.ncbi.nlm.nih.gov/21764822/ DOI: 10.1093/neuonc/nor077
- tissue_or_cell_type
- Glioblastoma
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell line cytotoxicity, tubulin polymerisation and syngeneic and xenograft orthotopic mouse glioma models · source_derived_draft · unverified_draft
### mbz-glioma-cytotoxicity In glioblastoma cell lines mebendazole displayed cytotoxicity with half-maximal inhibitory concentrations ranging from 0.1 to 0.3 micromolar, disrupted microtubule formation in those cells with in vitro activity correlated with reduced tubulin polymerization, and significantly extended mean survival by up to 63% in syngeneic and xenograft orthotopic mouse glioma models; the programme began with the serendipitous observation that fenbendazole, used to treat pinworm infection, inhibited brain tumour engraftment. Condition category: normal nutrient_topic: Mebendazole research collection; topical membership is not evidence of a direct clinical effect, and mebendazole is recorded separately from albendazole, from the benzimidazole class and from its own crystal forms. plain_language: The worm drug killed brain tumour cells at low concentrations and let mice live substantially longer. organism: Human cells and mouse tissue_or_cell_type: Glioblastoma experimental_model: Cell line cytotoxicity, tubulin polymerisation and syngeneic and xenograft orthotopic mouse glioma models limitations: The observation that started the programme was serendipitous, from pinworm treatment of laboratory animals. Mouse models, and the survival gain is a mean rather than a cure. exposure: Mebendazole compared with fenbendazole, at doses documented as safe in humans evidence_span: {"source_cache": "artifacts/mebendazole-research/21764822.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "31b328d5c2340f7a4e9b6a3b3d46c68a8c0265c50d483375bc6dc15bb1696ad6", "start_char": 0, "end_char": 1210, "text_sha256": "31b328d5c2340f7a4e9b6a3b3d46c68a8c0265c50d483375bc6dc15bb1696ad6"} [mbz-p21764822] Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme. (2011). https://pubmed.ncbi.nlm.nih.gov/21764822/ DOI: 10.1093/neuonc/nor077
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.